First randomised evidence for kinase inhibitor activity in acute myeloid leukaemia

Does the patient with myelofibrosis feel better through pacritinib?

Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease progression

Treatment and survival of patients with chronic myeloid leukaemia in Europe

Expert overview on the recent developments in mantle cell lymphoma

Round-up of the latest research on lung cancer

Lenvatinib increases progression free survival when used with everolimus in metastatic renal cell carcinoma

Medically under-represented populations: Refining the calculation of accrual targets

Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer

Screening to identify unsuitable candidates for ipilimumab in advanced melanoma

Nivolumab alone superior to ipilimumab alone in advanced melanoma

Extended adjuvant therapy for HER2-positive early breast cancer